Clinical trial
Phase I Trial of Periocular Topotecan in Retinoblastoma
NCT00460876 · Hospital JP Garrahan, Other · Completed
Key facts
| NCT number | NCT00460876 |
|---|---|
| Title | Phase I Trial of Periocular Topotecan in Retinoblastoma |
| Official title | Toxicity and Activity of Periocular Topotecan in Children With Retinoblastoma |
| Lead sponsor | Hospital JP Garrahan, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Retinoblastoma |
| Intervention type | Drug |
| Interventions | Topotecan |
| Enrollment | 5 |
| Start date | Mar 1, 2007 |
| Primary completion | Dec 1, 2007 |
| Completion | Apr 1, 2008 |
| First posted | Apr 17, 2007 |
| Last update posted | May 2, 2008 |
| Countries | Argentina |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: